The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients.
Ebina T, Fujimiya Y, Yamaguchi T, Ogama N, Sasaki H, Isono N, Suzuki Y, Katakura R, Tanaka K, Nagata K, Takano S, Tamura K, Uno K, Kishida T.
Ebina T, et al. Among authors: yamaguchi t.
Biotherapy. 1998;11(4):241-53. doi: 10.1023/a:1008047628284.
Biotherapy. 1998.
PMID: 9950100